Skip to content

Clinical trials

Phase 1 Multiple Myeloma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 1 Status: Unknown status Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20102
20142
20153
20161
20174
20189
201911
20209
202114
202211
20236
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital4
Shanghai Changzheng Hospital4
Zhejiang University4
Beijing Immunochina Medical Science & Technology Co., Ltd.2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
Chong Kun Dang Pharmaceutical2
Cylene Pharmaceuticals2
Hebei Senlang Biotechnology Inc., Ltd.2
Hebei Yanda Ludaopei Hospital2
Hrain Biotechnology Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma79
Recurrence13
Leukemia, Myeloid, Acute5
Breast Neoplasms4
Lymphoma, Non-Hodgkin4
Myelodysplastic Syndromes4
Burkitt Lymphoma3
Hodgkin Disease3
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.